当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析

药明康德

(603259)

  

流通市值:1683.62亿  总市值:1944.20亿
流通股本:25.01亿   总股本:28.88亿

药明康德(603259)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润95.68亿元,每股收益3.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益5908561.36万元,未分配利润3200764.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产8032582.44万元,负债2124021.08万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入39,241,431,359.8827,702,002,254.7617,240,918,263.027,981,934,236.96
营业总成本27,342,268,206.8819,967,164,047.6212,203,655,162.935,643,908,863.64
营业利润11,580,174,718.147,890,869,263.365,078,454,076.272,309,847,178.76
利润总额11,539,811,639.087,854,296,089.215,049,553,770.352,297,394,139.8
净利润9,567,739,539.186,601,611,515.974,280,845,682.911,958,853,204.95
其他综合收益185,718,884.52-3,353,834.7614,733,694.61-213,721,368.52
综合收益总额9,753,458,423.76,598,257,681.214,295,579,377.521,745,131,836.43
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计38,690,152,263.9930,462,748,877.1230,261,138,249.1131,153,381,549.19
非流动资产合计41,635,672,144.7643,775,490,998.1144,136,190,407.7843,786,466,187.38
资产总计80,325,824,408.7574,238,239,875.2374,397,328,656.8974,939,847,736.57
流动负债合计16,226,114,890.712,927,421,099.0213,648,375,448.3113,387,432,882.54
非流动负债合计5,014,095,882.485,727,576,674.225,654,192,029.35,504,117,842.47
负债合计21,240,210,773.1818,654,997,773.2419,302,567,477.6118,891,550,725.01
归属于母公司股东权益合计58,632,715,174.3755,173,547,660.3854,713,936,892.4755,639,487,743.34
股东权益合计59,085,613,635.5755,583,242,101.9955,094,761,179.2856,048,297,011.56
负债和股东权益合计80,325,824,408.7574,238,239,875.2374,397,328,656.8974,939,847,736.57
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计43,465,208,735.1431,246,847,172.8320,572,914,715.2910,421,436,141.23
经营活动现金流出小计31,058,693,900.5522,867,754,787.6815,606,620,527.928,164,318,333.37
经营活动产生的现金流量净额12,406,514,834.598,379,092,385.154,966,294,187.372,257,117,807.86
投资活动现金流入小计11,987,982,568.265,519,181,400.723,331,857,536.152,189,367,136
投资活动现金流出小计17,506,159,695.018,713,398,273.855,306,598,872.733,043,749,990.62
投资活动产生的现金流量净额-5,518,177,126.75-3,194,216,873.13-1,974,741,336.58-854,382,854.62
筹资活动现金流入小计11,986,352,535.198,282,155,280.665,575,838,145.112,929,323,063.97
筹资活动现金流出小计15,818,543,183.2214,187,039,758.569,037,526,297.462,972,618,043.21
筹资活动产生的现金流量净额-3,832,190,648.03-5,904,884,477.9-3,461,688,152.35-43,294,979.24
汇率变动对现金及现金等价物的影响387,525,345.81-9,427,113.53168,611,655.79156,482,470.23
现金及现金等价物净增加额3,443,672,405.62-729,436,079.41-301,523,645.771,515,922,444.23
期末现金及现金等价物余额13,444,711,217.649,271,602,732.619,699,515,166.2511,516,961,256.25
最新报告期:2025-03-25
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信建投刘若飞,贺菊颖3.794.354.972025-03-25
国盛证券张金洋,胡偌碧3.884.435.072025-03-23
西部证券徐子悦,李梦园3.864.485.162025-03-20
海通证券余文心,贺文斌3.904.525.142025-03-20
开源证券余汝意3.914.455.362025-03-20
TOP↑